NEXA
LIVE

Serial Number

79368445

Owner

Cochlear Limited

Attorney

WILLIAM M. BRYNER

Filing Date

Dec 23, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NEXA Trademark

Serial Number: 79368445 • Registration: 8190609

NEXA is a trademark filed by Cochlear Limited on December 23, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Cochlear Limited (61 trademarks)

Sydney NSW 2109 , AU

Entity Type: 03

Trademark Details

Filing Date

December 23, 2022

Registration Date

March 31, 2026

Published for Opposition

June 18, 2024

Goods & Services

Medical devices, namely, hearing aids, cochlear implants made from artificial materials and in-ear monitors for medical purposes, components of medical devices, namely, sound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; prosthetic hearing devices and components of prosthetic hearing devices, namely, hearing aids, sound processors and cochlear implants made from artificial materials adapted for use with prosthetic hearing devices; accessories for use with prosthetic hearing devices, namely, wireless transmitters and receivers for use with hearing aids; medical implants, namely, an implanted hearing device in the nature of a cochlear implant made from artificial materials, for delivering pharmaceutical preparations, medical preparations, pharmaceutical drugs, corticosteroids, dexamethasone, anti-inflammatory drugs, chemical reagents, or chemical preparations to the inner ear or auditory system of a human; none of the foregoing for laboratory-testing or medical-transport uses, and none of the foregoing non-implantable fluid-delivery containers, cartridges, syringes, vials, or test tubes sold for such uses

Downloadable and recorded software for managing clinical data; computer software, recorded for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; downloadable computer programs for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; computer software applications, downloadable for data analysis, databases management, and managing data for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; all the foregoing for use in the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; none of the foregoing in the field of digital imaging or digital image processing, analysis, measurement, display comparison or simulation of effects of surgical or product treatment outcomes

Pharmaceutical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; medical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; pharmaceutical drugs, namely, pharmaceutical preparations for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; corticosteroids; steroids, namely, dexamethasone; anti-inflammatory drugs; chemical reagents for medical purposes; chemical preparations for medical purposes, for the diagnosis, treatment, management or amelioration of inner ear or auditory system deficiencies; all the foregoing for or in relation to the inner ear or auditory system of a human; none of the foregoing for use in laboratory-testing or medical-transport applications, or packaged or sold primarily in connection with vials, test tubes, syringes, non-implantable cartridges, or non-implantable medical fluid containers for such applications

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 7, 2026 NREP
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 31, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 31, 2026 R.PR
TTAB RELEASE CASE TO TRADEMARKS
Mar 10, 2026 TMBN
OPPOSITION TERMINATED NO. 999999
Mar 10, 2026 OP.T
OPPOSITION DISMISSED NO. 999999
Mar 10, 2026 OP.D
REFUSAL PROCESSED BY IB
Jan 17, 2025 RFNT
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 17, 2024 ETOP
OPPOSITION INSTITUTED NO. 999999
Dec 16, 2024 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Dec 16, 2024 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Dec 15, 2024 OPNC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 12, 2024 OPNX
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 27, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 27, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 27, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 27, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 27, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 27, 2024 COAR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 25, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 25, 2024 OPNR
NOTIFICATION PROCESSED BY IB
Jul 1, 2024 GPNX
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 25, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 11, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 11, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
May 14, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 14, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
May 14, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 14, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 2, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 2, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 20, 2024 GNFN
FINAL REFUSAL E-MAILED
Apr 20, 2024 GNFR
FINAL REFUSAL WRITTEN
Apr 20, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 1, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 6, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 6, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 27, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 26, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 24, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 2, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 27, 2023 REPR